Imatinib Mesylate for Patients with Recurrent or Metastatic Gastrointestinal Stromal Tumors Expressing KIT: A Decade Experience from TaiwanChun‐Nan Yeh, Miin‐Fu Chen, Yi-Yin Jan et al.|Translational Oncology|2011Cited by 47
Kinase Mutations and Imatinib Mesylate Response for 64 Taiwanese with Advanced GIST: Preliminary Experience from Chang Gung Memorial HospitalChun‐Nan Yeh, Miin‐Fu Chen, Yi-Yin Jan et al.|Annals of Surgical Oncology|2006Cited by 34
Fas/Fas Ligand Mediates Keratinocyte Death in Sunitinib-Induced Hand-Foot Skin ReactionChun‐Nan Yeh, Wen‐Hung Chung, Shih‐Chi Su et al.|Journal of Investigative Dermatology|2014Cited by 30
Animal PET for Thioacetamide-Induced Rat Cholangiocarcinoma: A Novel and Reliable PlatformChun‐Nan Yeh, Miin-Fu Chen, Kun‐Ju Lin et al.|Molecular Imaging and Biology|2008Cited by 26
Imatinib escalation or sunitinib treatment after first-line imatinib in metastatic gastrointestinal stromal tumor patients.Chih-Chieh Hsu, Chun‐Nan Yeh, Chiao‐En Wu et al.|PubMed|2014Cited by 21